It is a link for moving within the page.

  1. HOME
  2. About Otsuka
  3. News Releases
  4. 2015
  5. E Keppra® Injectable, to be Launched in Japan on December 1; Will Contribute to Uninterrupted Treatment of Epilepsy Patients Aged 4 and Over with Partial-onset Seizures

November 26, 2015

Otsuka Pharmaceutical Co., Ltd.

Pharmaceuticals

E Keppra® Injectable, to be Launched in Japan on December 1; Will Contribute to Uninterrupted Treatment of Epilepsy Patients Aged 4 and Over with Partial-onset Seizures

Otsuka Pharmaceutical Co., Ltd. and UCB Japan Co., Ltd. are pleased to announce that E Keppra® for IV Drip Infusion 500 mg (levetiracetam) will be launched in Japan on December 1, 2015. Like its oral formulations, E Keppra® IV Drip Infusion will be indicated for partial-onset seizures (including secondary generalized seizures) in epilepsy patients as a temporary alternative when they are unable to ingest oral formulations.


Information in this news release was current as of the original release date.

Latest Pharmaceutical Business related News Releases

Most Recent Releases